Drugs / NBP615
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04453241 | Dec 2018 → Dec 2019 | cervical cancer | SK Bioscience Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NBP615 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04453241 ↗ |
| Modality | Vaccine | “test vaccine (NBP615)” NCT04453241 ↗ |